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to OCD classification in DSM-5 and ICD-11
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Summary
Obsessive-compulsive disorder (OCD) is no longer classified as an anxiety disorder in the fifth edition of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-5). It has become a flagship disorder of the new 
category of Obsessive Compulsive and Related Disorders (OCRDs) – a group of five disorders linked togeth-
er by the core symptom of repetitive thoughts and behaviors and phenomenological and neurobiological simi-
larity to OCD. Body dysmorphic disorder, hoarding disorder, trichotillomania, and skin picking disorder are the 
other disorders included in this group. In the upcoming eleventh edition of the International Classification of 
Diseases (ICD)-11, the World Health Organization (WHO) is planning to introduce similar changes to its own 
classification of OCD, further recommending the inclusion of olfactory reference disorder and hypochondri-
asis, in addition to the disorders listed in the DSM-5. In this article, we will review the classifications of OCD 
and OCDRs in the DSM-5 and the upcoming ICD-11, as well as describe the rationale and research leading 
to the creation of this new class of disorders.
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INTRODUCTION
Traditionally classified as one of the anxiety 
disorders in the Diagnostic and Statistical Man-
ual of Mental Disorders (DSM-IV and previous 
versions), in DSM-5 obsessive–compulsive dis-
order (OCD) is no longer part of the anxiety cat-
egory [1]. It was removed from the anxiety dis-
orders and reclassified under the new category 
of obsessive–compulsive and related disorders 
(OCRDs), which, in addition to OCD, includes 
four related disorders linked by a core symp-
tom of compulsivity and the presumed etiologi-
cal similarity to OCD. The International Classifica-
tion of Diseases, eleventh edition (ICD-11), due to 
be published in 2018, will likely follow suit with 
similar changes to its own OCD classification [2].
Psychopathology and diagnosis of OCD
OCD is a disabling neuropsychiatric condition 
characterized by the presence of unwanted ob-
sessive thoughts and repetitive behaviors. It af-
fects approximately 2–3% of the general popu-
lation and is present in all cultures worldwide 
[3]. The disorder typically begins early in life, 
equally affects males and females, and has a bi-
modal age of onset with peaks in early child-
hood and young adulthood [4]. Psychiatric co-
morbidities in OCD are more the rule than ex-
ception and up to 90% of individuals with OCD 
will meet criteria for at least one additional psy-
chiatric disorder [3,5]. These comorbidities fur-
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ther complicate the already difficult diagnosis 
and treatment of OCD.
The DSM-5 diagnostic criteria for OCD are rel-
atively straightforward and are essentially un-
changed from those found in the DSM-IV. They 
include the presence of time-consuming (at least 
1 hour per day) obsessions, compulsions or both. 
These symptoms are experienced as distressing 
and unreasonable, and are beyond the individ-
ual’s voluntary control. Although the presence 
of either obsessions or compulsions is sufficient 
for a diagnosis of OCD, DSM-5 acknowledges 
that most patients will present with both of these 
symptoms and that obsessions are typically pri-
mary to compulsions [1]. There is no requirement 
for a minimum duration of symptoms, but signif-
icant distress or dysfunction must be present. Al-
though anxiety is common in OCD, its presence 
is not required for a diagnosis. Because insight is 
recognized as closely correlated with treatment 
prognosis in OCD [6], it must now be assessed in 
all individuals receiving this diagnosis (and relat-
ed diagnoses of OCRDs). The level of insight in 
OCD may range from good to totally absent, and 
lack of insight, even of delusional quality, is no 
longer ground for an additional diagnosis of de-
lusional disorder [1]. It is important to note that 
the ICD-11 Working Group on OCD and related 
disorders is planning to introduce almost identical 
diagnostic guidelines to its own classification of 
OCD, thus significantly diverting from ICD-10 [2].
OCD AND OTHER ANXIETY DISORDERS
Phenomenology
Despite the apparent simplicity of diagnostic cri-
teria, OCD is a complex heterogeneous disorder 
that defies efforts at unitary classification within 
any single disorder category. Its symptomatolo-
gy is extremely diverse and the polythetic nature 
of OCD diagnostic criteria makes it possible for 
two people to meet full diagnostic requirements 
of OCD while sharing only the core symptom of 
repetitive behavior. The heterogeneity of OCD has 
been traditionally reduced by grouping symp-
toms into five content-based subtypes: (1) contam-
ination/washing; (2) harm/checking; (3) symme-
try/counting; (4) taboo thoughts/neutralizing be-
haviors; and (5) hoarding. Considerable evidence 
indicates that these subtypes are meaningfully 
distinct from each other in that they are associat-
ed with distinct genetic influences, comorbidities 
with other psychiatric disorders, neuropsycholog-
ical profiles and responses to treatment. Reducing 
the heterogeneity of OCD by clustering the disor-
der into smaller categories has had an important 
influence on the development of the current com-
pulsivity-based classification of OCD, because it 
showed that despite all their apparent differenc-
es, all these clusters share a common core symp-
tom repetitive behavior. On the other hand, anx-
iety symptoms were less consistently associated 
with various symptom manifestations of OCD [9].
Although OCD has been traditionally concep-
tualized as an anxiety disorder, with anxiety as 
its core feature, it was thought it was an awk-
ward fit. As early as 1990, the phenomenology 
of OCD was considered to be sufficiently distinct 
from other anxiety disorders to classify it in the 
ICD-10 as a separate disorder, albeit within the 
same main category as classic anxiety disorders. 
It has been noted, for example, that although ob-
sessions and compulsions are commonly accom-
panied by symptoms of anxiety, OCD may be as-
sociated with distressing experiences other than 
anxiety, such as disgust in contamination obses-
sions [7] or a sense of incompleteness and things 
“just not feeling right” in symmetry obsessions 
[8]. Furthermore, although obsessive thinking is 
common in all anxiety disorders, taboo obses-
sions, such as those related to sex, violence and 
religion, occur almost exclusively in OCD [9]. 
OCD compulsions are also quite distinct from 
avoidance behaviors in classic anxiety disorders 
in that they are more ritualistic and driven than 
avoidance behaviors in anxiety disorders. In ad-
dition, the severity of anxiety in OCD does not 
correlate strongly with measures of OCD severi-
ty and overall disability [10,11]. Epidemiological 
studies additionally show that OCD differs from 
anxiety disorders in several other ways, includ-
ing childhood onset in up to 50% of all patients 
[4], more variable comorbidity profiles [12,13], 
and more chronic waxing and waning course [3].
NEUROBIOLOGY
OCD neurobiology is also distinct from that in 
classic anxiety disorders. Whereas OCD is char-
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acterized by abnormalities in cortico-striatal 
neurocircuitry [14] and serotonin neurotrans-
mission [15], the neurobiology of anxiety more 
characteristically involves abnormalities in fron-
tal-limbic neurocircuitry [16]. OCD is also asso-
ciated with a characteristic pattern of cognitive 
impairment in executive functioning, including 
reduced mental flexibility, deficits in response 
inhibition and reduced capacity for planning 
[17,18]. Finally, OCD preferentially responds to 
treatment with serotonergic agents, such as clo-
mipramine and SSRIs [19], and cognitive–behav-
ioral therapy (CBT) with exposure and response 
prevention (ERP) [20]. On the other hand, oth-
er anxiety disorders respond to a much wider 
range of treatments, including benzodiazepines 
and forms of psychotherapy other than CBT.
Compulsivity as a core symptom of OCD
These lines of evidence have led to a dramatic 
shift in thinking about the core psychopathology 
of OCD, ultimately resulting in the proposal that 
compulsivity, defined as a tendency to engage in 
repetitive behaviors, is the core symptom of this 
disorder [21]. Compulsivity theory holds that al-
though repetitive behaviors may be accompa-
nied by other symptoms, such as anxiety or de-
pression, a compulsive urge, together with an in-
ability to modify the course of behavior, is the 
defining feature of OCD and other compulsive 
disorders. While the traditional learning model 
of OCD views compulsions as goal-directed be-
haviors that are performed to reduce anxiety as-
sociated with intrusive thoughts [22], a recently 
proposed habit-based conceptualization of com-
pulsivity theory puts forward a different view 
on the relationship between obsessions, compul-
sions and anxiety in OCD [23]. Thus, compul-
sions are best conceptualized as automatic, in-
flexible habits that have overrun and replaced 
an individual’s more adaptive goal-oriented 
problem-solving behaviors [23]. These habits are 
believed to be etiologically related to a dysreg-
ulation of cortico-striatal neurocircuitry, which 
leads to the breakdown of control over goal-ori-
ented behaviors with the consequent over-reli-
ance on the brain’s habit system. Unlike the clas-
sic learning model of OCD, compulsivity theo-
ry assumes that anxiety has no direct functional 
connection with compulsive symptoms. Never-
theless, it concedes that both stress and anxie-
ty make it more likely that goal-oriented prob-
lem-solving behaviors will be replaced by over-
learned, inflexible habits [23].
As conceptualized by Hollander [24,25], com-
pulsivity is a complex construct that can refer to 
a symptom of repetitive behavior, part of a syn-
drome or disorder (such as OCD), or a group 
of disorders with prominent obsessive or com-
pulsive features. In its broadest sense, the term 
compulsivity refers to a transdiagnostic con-
struct that links many diverse neuropsychiatric 
disorders. Included in that group are OCD, so-
matic anxiety disorders, such as body dysmor-
phic disorder (BDD), somatization disorder and 
hypochondriasis; eating disorders, such as ano-
rexia nervosa, bulimia nervosa and binge eating 
disorder; impulse control disorders, such as tri-
chotillomania and kleptomania; addictive disor-
ders, such as gambling disorder, sex addiction 
and shopping addiction; personality disorders, 
such as obsessive compulsive personality dis-
order (OCPD); and neurological disorders with 
prominent perseverative features, such as tic dis-
order, Tourette’s disorder and autism. Although 
these disorders all share the core feature of re-
petitive behaviors, they differ in terms of where 
they can be placed on the dimension of com-
pulsivity–impulsivity [25]. Whereas the disor-
ders with primarily compulsive features, such as 
OCD, BDD and anorexia nervosa, are character-
ized by risk aversion, harm avoidance, increased 
serotonin function and underlying abnormali-
ties in dorsal cortico-striatal neurocircuitry, dis-
orders with predominantly impulsive features, 
such as pathological gambling, kleptomania and 
binge eating, are impulsive, driven by pleasure 
seeking and characterized by decreased seroto-
nin function and underlying abnormalities in 
the ventral cortico-striatal circuitry [26]. In ad-
dition, many disorders, such as trichotilloma-
nia, autism and Tourette’s disorder, are neither 
entirely compulsive nor impulsive; rather, to 
a large degree, they appear to share both com-
pulsive and impulsive features [25]. Despite im-
portant differences, compulsive and impulsive 
behaviors share many common features, includ-
ing the experience of diminished control over 
own behavior and a tendency to persevere with 
the same non-functional habits despite obvious 
negative consequences. Moreover, compulsive 
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and impulsive disorders tend to share similar 
disease burden characteristics, including young 
age at onset, high rates of comorbidity and mis-
diagnosis, chronic course with unpredictable re-
sponse to treatment, high level of occupational 
and social disability, and a high socioeconomic 
cost to society [27].
Candidate OCRDs
In recommending which compulsive disorders 
should accompany OCD in the new category 
of OCRDs, the DSM-5 and the ICD-11 working 
groups made a preliminary decision to only in-
clude those disorders that are experienced as 
unwanted and associated with distress or other 
ego-dystonic features [28]. Consequently, con-
ditions from the strongly impulsive end of the 
spectrum, such as pathological gambling, sex-
ual addiction, compulsive shopping, binge eat-
ing, and other impulsive disorders associated 
with pleasurable experiences, were excluded 
from further consideration. This decision found 
a middle ground between, on the one hand, 
those who were against any changes to the ex-
isting OCD classification [29] or who proposed 
a joint category of anxiety and obsessive–com-
pulsive disorders [30] and, on the other, those 
who favored a broad transdiagnostic catego-
ry of compulsive–impulsive disorders [21,24]. 
This decision was consistent with emerging ge-
netic, familial and comorbidity studies showing 
that addictive disorders and eating disorders are 
likely not genetically related to OCD [12].
It was a decision that also concurred with pop-
ular opinion among 187 OCD expert clinicians 
and researchers who, in a survey conducted by 
Mataix et al. [31], were asked whether they were 
in favor of removing OCD from the category of 
anxiety disorders in the upcoming 5thedition of 
the DSM; and, assuming that the new catego-
ry of OCRDs would be created in DSM-5, they 
were asked about their preferred choice of dis-
orders for this category. The results indicated 
that 60% of experts (mostly psychiatrists) were 
in favor of removing OCD from the category of 
anxiety disorders and 40% (mostly psychologists 
and related professionals) were against. Most re-
spondents believed that a new category of OCD 
disorders should be small; thus, it should only 
include BDD (72%), trichotillomania (70%), tic 
disorders (61%) and hypochondriasis (57%). 
Fifty-five percent were against the inclusion of 
OCPD and the vast majority disapproved of the 
inclusion of impulse control disorders other than 
trichotillomania (67% ), eating disorders (72%), 
autism (91%), and addictions (95%) [30,31].
The final selection of disorders to be includ-
ed in the OCRDs category in DSM-5 and ICD-
11 was guided by the idea that the disorders 
should, as much as possible, be phenomeno-
logically and neurobiologically related to OCD, 
and be distinct from anxiety disorders and oth-
er groups of disorders. Each candidate disor-
der was evaluated on a number of diagnostic 
validators, including symptomatology, comor-
bidity, familial aggregation, genetic risk fac-
tors, brain circuitry, neuropsychological profile 
and response to treatment, and was only rec-
ommended for inclusion in the OCRDs group-
ing if at least several of these criteria were met 
[24,30]. Thus, the following disorders were se-
lected: OCD, BDD, hoarding disorder, tricho-
tillomania and skin picking disorder. Hoarding 
disorder and skin picking disorder are new dis-
orders in DSM-5, and BDD and trichotillomania 
are reclassifications from the somatoform disor-
ders and impulse control disorders, respectively.
Although a final decision on the ICD-11 classi-
fication of OCRDs will not be known until ear-
ly 2018, the current proposal, as described by 
Stein et al. [2] is that, in addition to OCD and 
the OCRDs already listed in DSM-5, the ICD-11 
grouping of OCRDs will also include a new cat-
egory of olfactory reference disorder and the for-
mer somatoform disorder of hypochondriasis. In 
addition, Tourette’s disorder and OCPD, which 
will continue to be listed in their respective diag-
nostic groupings in ICD-11, will be cross-refer-
enced to the OCRDs chapter to emphasize their 
phenomenological connection with OCD [2]. 
Other than the difference in the number of dis-
orders included in the grouping, it would ap-
pear that the DSM-5 and ICD-11 classifications 
of OCRDs are essentially parallel classifications. 
The only other, relatively minor, difference that 
should be mentioned here is in the handling 
of trichotillomania and skin picking disorder. 
While these disorders are classified as distinct 
OCRDs in DSM-5, it is proposed they are clus-
tered under the larger subcategory of body-fo-
cused repetitive disorders in ICD-11.
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OCRDS SELECTED FOR DSM-5 AND ICD-11
Body dysmorphic disorder
Of all the OCD-related disorders, BDD has the 
most common features with OCD. BDD involves 
a persistent obsession about a nonexistent or 
slight defect in physical appearance that causes 
significant distress or dysfunction [32]. In addi-
tion, individuals with BDD commonly engage in 
repetitive behaviors aimed at reassurance seek-
ing, checking, hiding or fixing the presumed 
defect. Like OCD, BDD occurs early in life, is 
equally common in males and females, and has 
a chronic waxing and waning course with symp-
toms exacerbated under stress [32]. In addition, 
comorbidity rates are high for OCD and BDD, 
and the prevalence of BDD is elevated in first-
degree relatives of individuals with OCD [17]. 
Other lines of evidence suggest that BDD shows 
similarities with OCD in terms of its neural sub-
strates [33] and preferential response to treat-
ment with SSRIs and with CBT/ERP [34]. How-
ever, insight is typically much poorer in BDD 
than in OCD [32].
Olfactory reference disorder
With diagnostic symptom criteria almost identi-
cal to BDD, olfactory reference disorder involves 
preoccupation with the idea of having foul body 
odor or breath. The perceived unpleasant smell 
is either imagined or hardly apparent to oth-
ers. Preoccupations can focus on smells origi-
nating from one or more body areas, including 
the mouth, anus, genitals, underarms, feet, or 
urine or sweat [35]. Similar to BDD, individu-
als with olfactory reference disorder engage in 
repetitive mental acts and behaviors, including 
frequent showering, seeking (non-psychiatric) 
medical help, sniffing body parts in search of the 
source of the smell, and adopting various odor-
camouflaging strategies. Available evidence sug-
gests that olfactory reference disorder shares co-
morbidity with OCD and that it also shares re-
sponse to SSRIs and CBT typical of OCD and 
other OCD-related disorders [35,36].
Hypochondriasis
Hypochondriasis is well known to psychiatry as 
a somatic preoccupation disorder that is charac-
terized by obsessive thoughts about having a se-
rious undiagnosed medical illness. In terms of 
its symptoms, hypochondriasis resembles both 
OCD and BDD in that, in addition to obsessive 
thinking about being ill, it also involves prom-
inent compulsive behaviors, including reassur-
ance seeking, health-information search and oth-
er health-checking behaviors. Like OCD, hypo-
chondriasis typically follows a chronic course 
[37]. Comorbidity studies support the link with 
OCD [5,12]. However, although hypochondri-
asis has been shown to respond to SSRIs and 
CBT/ERP, it is unclear whether these are pref-
erential or if they are just one of several effec-
tive modes of treatment for the disorder [38,39]. 
Furthermore, the placebo effect was found to be 
much higher in hypochondriasis than in OCD 
and withdrawal of treatment with fluoxetine 
did not result in the recurrence of symptoms 
[40]. Other diagnostic validators, including ge-
netic risk factors and neural circuitry, have not 
shown strong evidence of a preferential link be-
tween OCD and hypochondriasis [41]. Based on 
this and similar evidence, the ICD-11 Working 
Group has decided to add hypochondriasis to 
the OCRDs grouping in ICD-11 [2]. On the oth-
er hand, the American Psychiatric Association 
has recommended against the reclassification of 
hypochondriasis into a compulsive disorder in 
DSM-5, citing lack of sufficient evidence that hy-
pochondriasis is etiologically more strongly re-
lated to OCD than to somatic disorders [30].
Hoarding disorder
Previously listed as one of the symptom sub-
types of OCD, hoarding became a distinct 
OCRDs disorder in DSM-5 [1]. It is also one of 
the disorders proposed for inclusion in ICD-11 
[2]. Hoarding disorder involves excessive col-
lecting and difficulty discarding personal pos-
sessions resulting in clutter, which interferes 
with normal functioning and safety. Although 
it shares some symptom similarities with OCD, 
the ego-syntonic nature of acquiring and hold-
ing onto things also resembles some impulse 
control disorders, particularly compulsive shop-
ping [42]. Research shows that hoarding behav-
iors are common in individuals with OCD and 
severe hoarders have a significantly increased 
lifetime risk of OCD [43]. Like OCD, hoarding 
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disorder typically has a chronic lifelong course 
but, unlike OCD, it is more often associated with 
stable rather than waxing and waning symptom-
atology. Despite earlier reports to the contrary 
[19], response to treatment with SSRIs does oc-
cur in hoarding disorder [44], although it is less 
robust than in OCD. In addition, while CBT/ERP 
are largely ineffective [45], CBT therapies based 
specifically on hoarding models have shown 
more promise [46]. However, the neurobiol-
ogy of hoarding disorder is likely distinct from 
the neurobiology of OCD, as hoarding disorder 
tends to rely on fronto-limbic connections rath-
er than on cortico-striatal circuitry [47].
Trichotillomania and skin picking disorder
Trichotillomania and skin picking disorder are 
phenomenologically two very similar body-fo-
cused disorders that are characterized by recur-
rent, time-consuming habitual pulling of hair or 
picking of skin resulting in significant distress, 
physical disfigurement and functional impair-
ment [48]. Like OCD, they involve repetitive, un-
wanted and ritualistic behaviors that are difficult 
to resist or control. However, unlike in OCD, 
these compulsive behaviors are typically not 
preceded by obsessions or intrusive thoughts, 
though various negative emotions, such as ten-
sion, sadness or anxiety, may precede them. 
Both disorders show female preponderance. 
Age at onset is typically early to middle ado-
lescence in trichotillomania and has a narrower 
range than in skin picking disorder, which may 
begin at any age in childhood, adolescence or 
adulthood [48]. Comorbidity studies show that 
lifetime prevalence rates of trichotillomania are 
elevated in patients with OCD, and the risk of 
OCD is higher in individuals who initially pre-
sent with trichotillomania. In addition, rates of 
trichotillomania are increased in first-degree rel-
atives of individuals with OCD [12]. Trichotillo-
mania also shares a strong similarity with OCD 
in terms of underlying abnormalities in corticos-
triatal pathways as well as some associated im-
pairments in the cognitive abilities linked to the 
integrity of these brain structures [18,49]. How-
ever, in contrast to OCD, trichotillomania is not 
consistently responsive to serotonin-based phar-
macotherapy; it also shows a better response 
to an non-selective serotonin reuptake inhibi-
tor clomipramine than to SSRIs [50]. Therefore, 
CBT is typically recommended as the first line 
of treatment for trichotillomania, especially in 
children [48]. Research shows that trichotilloma-
nia responds to treatment with CBT, although it 
generally shows a preferential response to hab-
it reversal training than to ERP [51].
THE NEW CATEGORY – OCRDS
It should be noted that the new classification 
of OCD as a compulsive disorder is controver-
sial. In fact, three years after the publication of 
DSM-5, many OCD clinicians and researchers 
still argue that the removal of OCD from the cat-
egory of anxiety disorders and the creation of 
a new category of obsessive–compulsive relat-
ed disorders was arbitrary and not sufficiently 
supported by evidence [22]. The most conten-
tious issue in this nosological controversy still 
centers on the question of whether OCD is bet-
ter conceptualized as an anxiety disorder or as 
a compulsive disorder. However, growing re-
search indicates that this question may no longer 
be appropriate, since converging evidence from 
clinical, genetic, comorbidity and neurobiologi-
cal studies suggests that OCD and anxiety dis-
orders can never be clearly separated into two 
entirely independent diagnostic categories. Clin-
ical experience shows that reports of fear and 
anxiety are very high in OCD and are compara-
ble to those seen in other anxiety disorders [29]. 
In addition, recent genetic evidence shows that 
OCD shares common risk factors with both anx-
iety disorders and obsessive–compulsive disor-
ders. For example, in a large population-based 
twin study [52] that investigated genetic overlap 
and pattern of etiological relationships among 
a group of OCRDs (hoarding disorder and BDD) 
and a group of anxiety disorders (social phobia, 
panic disorder and generalized anxiety disor-
der), the proportion of common genetic vari-
ance in OCD symptoms was higher when mod-
eling with both groups of disorders than when 
modeling with the OCRDs group alone. These 
results support the idea that OCD is a complex 
disorder that shares genetic features with both 
anxiety disorders and OCRDs [52].
Findings from comorbidity and familial stud-
ies also support the view that OCD is related 
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both to anxiety disorders and disorders on the 
OCD spectrum. In the study of Bienvenu et al. 
[12], individuals with OCD were more likely 
than control subjects to have elevated lifetime 
rates of both OCRDs and anxiety disorders. 
The parallel albeit somewhat less robust pattern 
was demonstrated in first-degree relatives of in-
dividuals with OCD in comparison with con-
trol subjects [12]. Finally, neuroimaging and an-
atomical studies indicate that the neurocircuit-
ries of compulsivity and anxiety cannot be as 
easily disentangled as previously thought. An-
atomical studies show that substantial portions 
of the cortical-striatal neurocircuitry implicat-
ed in OCD have important connections with the 
amygdala and other brain regions that mediate 
fear and anxiety [53,54]. Evidence from neuro-
imaging studies further indicates that a dysfunc-
tion of cortico-striatal circuitry may not be the 
only neural mechanism mediating OCD symp-
toms, and that lateral and medial orbitofrontal 
cortices, the dorsal anterior cingulate cortex and 
the amygdala that mediate fear and anxiety may 
be equally important in the pathophysiology of 
OCD [54].
Collectively, these findings suggest that the 
compulsivity model of OCD may be overly sim-
plistic and that the model incorporating anxiety, 
and possibly depression [11,55] in addition to 
compulsivity, may better capture the complex 
psychopathology of OCD. Future studies are 
needed to validate the diagnostic validity and 
clinical utility of the new classification of OCD 
and related disorders and to further elucidate 
the essential genetic relationship and other cor-
relations among OCD, related disorders, anx-
iety, depression, and other disorders from the 
compulsivity – impulsivity spectrum.
REFERENCES
1. American Psychiatric Association. Diagnostic and Statistical 
Manual Of Mental Disorders, 5th ed (DSM-5). Washington, 
DC: American Psychiatric Association; 2013.
2. Stein DJ, Kogan CS, Atmaca M, Fineberg NA, Fontenel-
le LF, Grant JE et al. The classification of Obsessive Com-
pulsive Disorders in the ICD-11. J Affect Disord. 2016; 190: 
663–674.
3. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemi-
ology of obsessive compulsive disorder in the National Co-
morbidity Survey Replication. Mol Psychiatry. 2010; 15(1): 
53–63.
4. Geller DA. Obsessive-compulsive and spectrum disorders 
in children and adolescents. Psychiatr Clin North Am. 2006; 
29(2): 353–370.
5. LaSalle VH, Cromer KR, Nelson KN, Kazuba D, Justement 
L, Murphy DL. Diagnostic interview assessed neuropsy-
chiatric disorder comorbidity in 334 individuals with obses-
sive-compulsive disorder. Depress Anxiety. 2004; 19(3): 
163–173.
6. Ravi Kishore V, Samar R, Janardhan Reddy YC, Chan-
drasekhar CT, Thennarasu K. Clinical characteristics and 
treatment response in poor and good insight obsessive com-
pulsive disorder. Eur Psychiatry. 2004; 19(4): 202–208.
7. Olatunji BO, Ebesutani C, David B, Fan Q, McGrath PB. 
Disgust proneness and obsessive-compulsive symptoms in 
a clinical sample: a structural differentiation from negative af-
fect. J Psychiatr Res. 2011; 25(7): 932–938.
8. Summerfeldt LJ. Understanding and treating incomplete-
ness in obsessive-compulsive disorder. J Clin Psychol. 2004; 
60(11): 1155–1168.
9. Stein DJ, Fineberg NA, Bienvenu OJ, Denys D, Lochner C, 
Nestadt G, et al. Should OCD be classified as an anxiety 
disorder in DSM-V. Depress Anxiety. 2010; 27(6): 495–506.
10. Storch EA, Abramowitz JS, Keeley M. Correlates and medi-
ators of functional disability in obsessive-compulsive disor-
der. Depress Anxiety. 2009; 26(9): 806–813.
11. Storch EA, Larson MJ, Muroff J, Caporino N, Geller D, Reid 
JM, et al. Predictors of functional impairment in pediatric 
OCD. J Anxiety. 2010; 24(2): 275–283.
12. Bienvenu, OJ, Samuels JF, Wuyek LA, Liang KY, Wang Y, 
Grados MA, et al. Is obsessive-compulsive disorder an anxie-
ty disorder, and what, if any, are spectrum conditions? A fam-
ily study perspective. Psychol Med. 2012; 42: 1–13.
13. Brown TA, Cambell LA, Lehman CL, Grisham JR, Manci RB. 
Current and lifetime comorbidity of DSM-IV anxiety and mood 
disorders in a large clinical sample. J Abnorm Psychol. 2001; 
110: 585–599.
14. Saxena S, Brody Al, Schwartz JM, Baxter LB. Neuroimaging 
and frontal-subcortical circuitry in obsessive-compulsive dis-
order. Br J Psychiatry 1998; 35 (Suppl.): s26–37.
15. Murphy DL, Moya PR, Fox MA, Rubenstein, LM, Wendland 
JR, Timpano KR. Anxiety and affective disorder comorbidity 
related to serotonin and other neurotransmitter systems: ob-
sessive-compulsive disorder as an example of overlapping 
clinical and genetic heterogeneity. Philos Trans R Soc Lond 
Biol Sic. 2013; 368(1615): 20120435.
16. Taylor JM, Whalen PJ. Neuroimaging and anxiety: the neu-
ral substrates of pathological and non-pathological anxiety. 
Curr Psychiatry Rep. 2015; 17: 49.
17. Hashimoto N, Nakaaki S, Omori IM, Fujioi J, Noguchi Y, Mu-
rata Y, et al. Distinct neuropsychological profiles of three ma-
jor symptom dimensions in obsessive-compulsive disorder. 
Psychiatry Res. 2011; 187(1-2): 166–173.
14	 Eliza	Krzanowska,	Małgorzata	Kuleta
Archives of Psychiatry and Psychotherapy, 2017; 3: 7–15
18. Chamberlain SR, Fineberg NA, Blackwell AD, Robbins TW, 
Sahakian BJ. Motor inhibition and cognitive flexibility in ob-
sessive-compulsive disorder and trichotillomania. Am J Psy-
chiatry. 2006; 163(7): 1282–1284.
19. Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L. 
Use of factor-analyzed symptom dimensions to predict out-
come with serotonin reuptake inhibitors and placebo in the 
treatment of obsessive-compulsive disorder. Am J Psychia-
try.1999; 156: 1409–1416.
20. McKay D, Sookman D, Neziroglu F, Wilhelm S, Stein DJ, 
Kyrios M, et al. Accreditation Task Force of the Canadian In-
stitute for Obsessive Compulsive Disorders. Efficacy of cog-
nitive-behavioral therapy for OCD. Psychiatry Res. 2015; 30: 
227(1): 104–113.
21. Hollander E, Braun A, Simeon D. Should OCD leave the anxi-
ety disorders in DSM-V? The case for obsessive-compulsive-
related disorders. Depress Anxiety. 2008; 25(4): 317–329.
22. Abramovitz JS, Jacoby RJ. Obsessive-compulsive and re-
lated disorders: a critical review of the new diagnosis. Annu 
Rev Clin Psychol. 2015; 11: 165–186.
23. Gillan CM, Robbins TW, Sahakian BJ, van den Heuvel OA, 
van Wingen G. The role of habit in compulsivity. Eur Neu-
ropsychopharmacol. 2016; 26: 828–840.
24. Hollander E. Anxiety and obsessive-compulsive spectrum 
disorders over life cycle. Int J Psychiatry Clin Pract. 2007; 
11(Suppl. 2): 5–10.
25. Berlin GS, Hollander E. Compulsivity, impulsivity, and the 
DSM-5 process. CNS Spectrums. 2014; 19: 62–68.
26. Van den Heuvel OA, van Wingen G, Soriano-Mas C, Alonso 
P, Chamberlain SR, Nakamae T, et al. Brain circuitry of com-
pulsivity. Eur Neuropsychopharmacol. 2016; 26: 810–827.
27. Hollander E, Doernberg E, Shavitt R, Waterman RJ, Soreni 
N, Veltman DJ, et al. The cost and impact of compulsivity. 
Eur Neuropsychopharmacol. 2016; 26: 800–809.
28. Murphy DL, Timpano KR, Wheaton MG, Greenberg BD, 
Miguel EC. Obsessive-compulsive disorder and its related 
disorders: a reappraisal of obsessive-compulsive spectrum 
concepts. Dialogues Clin Neurosc. 2010; 12: 131–148.
29. Storch EA, Abramowitz JS, Goodman WK. Where does ob-
sessive-compulsive belong in DSM-V? Depress Anxiety. 
2008; 25: 336–347.
30. Phillips KA, Stein DJ, Rouch SL, Hollander E, Fallon BA, 
Barsky A, et al. Should an obsessive-compulsive spectrum 
grouping of disorders be included in DSM-V? Depress Anx-
iety. 2010; 27: 528–555.
31. Mataix-Cols D, Pertusa A, Leckman JF. Issues for DSM-V: 
How should OCD and related disorders be classified. Am J 
Psychiatry. 2007; 164(9): 1313–1314.
32. Bjornsson AS, Didie ER, Phillips KA. Body dysmorphic disor-
der. Dialogues Clin Neurosci. 2010; 12(22): 221–232.
33. Rauch SL, Phillips KA, Segal E, Makris N, Shin LM, Whalen 
PJ, et al. A preliminary morphometric magnetic resonance 
imaging study of regional brain volumes in body dysmorphic 
disorder. Psychiatry Res. 2003; 122(1): 13–19.
34. Ipser JC, Sander C, Stein DJ. Pharmacotherapy and psycho-
therapy for body dysmorphic disorder. Cochrane Database 
Syst Rev. 2009; 1: CD005332.
35. Phillips KA, Menard W. Olfactory reference syndrome: de-
mographic and clinical features of imagined body odor. Gen 
Hosp Psychiatry. 2011; 33(4): 398–406.
36. Pal Singh G. Is olfactory reference syndrome an OCD? Indi-
an J Psychiatry. 2006; 48(3): 201–202.
37. Olde Hartman TC, Borghuis MS, Lucassen PL, van de Laar 
FA, Speckens AE, van Weel C. Medically unexplained symp-
toms, somatization disorder and hypochondriasis: course 
and prognosis. A systematic review. J Psychosom Res. 2009; 
66(5): 363–377.
38. Thomson AB, Page LA. Psychotherapy for hypochondriasis. 
Cochrane Database Syst Rev. 2007; 4: CD006520.
39. Somashekar B, Jainer A, Wuntakal. Psychopharmacothera-
py of somatic symptoms disorders. Int Rev Psychiatry. 2013; 
25(1): 107–115.
40. Fallon BA, Schneider FR, Marshall R, Campeas R, Vermes 
D, Goetz D, et al. The pharmacotherapy of hypochondriasis. 
Psychopharmacol Bull. 1996; 32(4): 607–611.
41. Van den Heuvel OA, Veltman DJ, Groenewegen HJ, Witter 
MP, Merkelbach J, Cath DC et al. Disorder-specific neuro-
anatomical correlates of attentional bias in obsessive-com-
pulsive disorder, panic disorder, and hypochondriasis. Arch 
Gen Psychiatry. 2005; 62(8): 922–933.
42. Steketee G, Frost R. Compulsive hoarding: current status 
of the research. Clin Psychol Rev. 2003; 23(7): 905–927.
43. Frost RO, Krause MS, Steketee G. Hoarding and obses-
sive-compulsive symptoms. Behav Modif. 1996; 20(1): 
116–132.
44. Saxena, S. Pharmacotherapy of compulsive hoarding. J Clin 
Psychol. 2011; 67(5): 477–484.
45. Abramowitz JS, Franklin ME, Schwartz SA, Furr JM. 
Symptom presentation and outcome of cognitive-behav-
ioral therapy for OCD. J Consult Clin Psychol. 2003; 71(6): 
1049–1057.
46. Tolin DF, Frost RO, Steketee G. An open trial of cognitive-be-
havioral therapy for compulsive hoarding. Behav Res Ther. 
2007; 45(7): 1461–1470.
47. Mataix-Cols D, Pertusa A, Snowdon J. Neuropsychological 
and neural correlates of hoarding: a practice-friendly review. 
J Clin Psycho. 2011; 67: 467–476.
48. Grant JE, Chamberlain SR. Trichotillomania and skin picking 
disorder: different kinds of OCD. Focus. 2015; 13(2): 184–
189.
49. Chamberlain SR, Odlaug BL, Boulougouris V, Fineberg NA, 
Grant JE. Trichotillomania: neurobiology and treatment. Neu-
rosci Biobehav Rev. 2009; 33(6): 831–842.
	 From	anxiety	to	compulsivity	–	a	review	of	changes	to	OCD	classification	in	DSM-5	and	ICD-11	 15
Archives of Psychiatry and Psychotherapy, 2017; 3: 7–15
50. Rothbart R, Amos T, Siegfried N, Ipser JC, Fineberg N, 
Chamberlain SR, et al. Pharmacotherapy for trichotilloma-
nia. Cochrane Database Syst Rev. 2013; 11: CD007662.
51. Franklin ME, Zagrabbe K, Benavides KL. Trichotillomania 
and its treatment: a review and recommendations. Expert 
Rev Neurother. 2011; 11(8): 1165–1174.
52. Lopez-Sola C, Fontenelle LF, Bui M, Hopper JL, Pantelis C, 
Yucel M, et al. Aetiological overlap between obsessive-com-
pulsive related and anxiety disorder symptoms: multivariate 
twin study. B J Psychiatry. 2016; 208(1): 26–33.
53. Haber SN, Knutson B. The reward circuit: Linking primate 
anatomy and human imaging. Neuropsychopharmacology. 
2010; 35(1): 4–26.
54. Milad MR, Rauch SL. Obsessive compulsive disorder: Be-
yond segregated cortico-striatal pathways. Trends Cogn Sci. 
2012; 16(1): 43–51.
55. Goodwin GM. The overlap between anxiety, depression and 
OCD. Dialogues Clin Neurosci 2015; 17(3): 249–260.
